Page last updated: 2024-12-10

5-nitro-6,7,8,9-tetrahydrobenzo(g)indole-2,3-dione-3-oxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime: a non-NMDA receptor antagonist; shows selective displacement of low-affinity kainate binding; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4461601
CHEMBL ID9750
CHEBI ID34880
SCHEMBL ID2281310
SCHEMBL ID8294945
MeSH IDM0223971

Synonyms (27)

Synonym
PDSP2_001825
PDSP1_001842
136623-01-3
ns-102
N179_SIGMA ,
ns 102, solid
CHEMBL9750
1h-benz(g)indole-2,3-dione, 6,7,8,9-tetrahydro-5-nitro-, 3-oxime
5-nitro-6,7,8,9-tetrahydrobenzo(g)indole-2,3-dione-3-oxime
3-(hydroxyamino)-5-nitro-6,7,8,9-tetrahydrobenzo[g]indol-2-one
1h-benz[g]indole-2,3-dione,6,7,8,9-tetrahydro-5-nitro-, 3-oxime
unii-00978e5h3r
00978e5h3r ,
6,7,8,9-tetrahydro-5-nitro-1h-benz[g]indole-2,3-dione 3-oxime
pd-139977
5-nitro-6,7,8,9-tetrahydro-1h-benzo(g)indole-2,3-dione 3-oxime
CHEBI:34880
SCHEMBL2281310
SCHEMBL8294945
DTXSID30159858
6,7,8,9-tetrahydro-5-nitro-1h-benz[g]indole-2,3-dione-3-oxime
Q6955233
5-nitro-3-nitroso-6,7,8,9-tetrahydro-1h-benzo[g]indol-2-ol
MS-23679
HY-114427
CS-0085294
AKOS040756691
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]